pneumocandin B0

Pneumocandin B0 is a natural lipopeptide antifungal compound produced through the fermentation of the fungus *Glarea lozoyensis*. It serves as a critical intermediate and precursor for the semi-synthetic production of caspofungin acetate (brand name Cancidas), a widely used echinocandin antifungal medication. Developed by JC Biotech Pvt. Ltd. with a focus on scale-up and optimization of production and purification, pneumocandin B0 exerts its antifungal activity by inhibiting the enzyme β-(1,3)-D-glucan synthase. This enzyme is essential for the synthesis of β-(1,3)-D-glucan, a major structural component of the fungal cell wall. Inhibition of this target leads to osmotic instability and subsequent lysis of the fungal cell. While pneumocandin B0 possesses intrinsic antifungal properties, its primary commercial and pharmaceutical value is as a starting material for approved echinocandin derivatives.

Other names

pneumocandin B0L-688,786Pneumocandin B(0)